Supernus Pharmaceuticals
SUPN
$29.81
Share price
-1.49%
Change (1 day)
-20.95%
Change (1 year)
Categories
EPS for Supernus Pharmaceuticals (SUPN)
EPS in 2023 (TTM): $0.79
According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.79. In 2022 the company made an earnings per share (EPS) of $1.13 an increase over its 2021 EPS that were of $1.02.
EPS history for Supernus Pharmaceuticals from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.79 | -30.09% |
| 2022 | $1.13 | 10.78% |
| 2021 | $1.02 | -57.68% |
| 2020 | $2.41 | 12.09% |
| 2019 | $2.15 | 0.47% |
| 2018 | $2.14 | 89.38% |
| 2017 | $1.13 | -38.59% |
| 2016 | $1.84 | 534.48% |
| 2015 | $0.29 | -211.54% |
| 2014 | -$0.26 | -91.1% |
| 2013 | -$2.92 | 39.46% |
| 2012 | -$2.09 | -69.27% |
| 2011 | -$6.81 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 1,682.95% | 🇺🇸 USA |
 Abbott Laboratories ABT | $2.97 | 276.23% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 587.25% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | 402.53% | 🇺🇸 USA |
 United Therapeutics UTHR | $19.32 | 2,345.57% | 🇺🇸 USA |